Your browser doesn't support javascript.
loading
Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study.
Behary, Preeshila; Tharakan, George; Alexiadou, Kleopatra; Johnson, Nicholas; Wewer Albrechtsen, Nicolai J; Kenkre, Julia; Cuenco, Joyceline; Hope, David; Anyiam, Oluwaseun; Choudhury, Sirazum; Alessimii, Haya; Poddar, Ankur; Minnion, James; Doyle, Chedie; Frost, Gary; Le Roux, Carel; Purkayastha, Sanjay; Moorthy, Krishna; Dhillo, Waljit; Holst, Jens J; Ahmed, Ahmed R; Prevost, A Toby; Bloom, Stephen R; Tan, Tricia M.
Afiliação
  • Behary P; Section of Investigative Medicine, Imperial College London, London, U.K.
  • Tharakan G; Section of Investigative Medicine, Imperial College London, London, U.K.
  • Alexiadou K; Section of Investigative Medicine, Imperial College London, London, U.K.
  • Johnson N; Imperial Clinical Trials Unit, Imperial College London, London, U.K.
  • Wewer Albrechtsen NJ; Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.
  • Kenkre J; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Cuenco J; Section of Investigative Medicine, Imperial College London, London, U.K.
  • Hope D; Section of Investigative Medicine, Imperial College London, London, U.K.
  • Anyiam O; Section of Investigative Medicine, Imperial College London, London, U.K.
  • Choudhury S; Section of Investigative Medicine, Imperial College London, London, U.K.
  • Alessimii H; Section of Investigative Medicine, Imperial College London, London, U.K.
  • Poddar A; Section of Investigative Medicine, Imperial College London, London, U.K.
  • Minnion J; Section of Investigative Medicine, Imperial College London, London, U.K.
  • Doyle C; Section of Investigative Medicine, Imperial College London, London, U.K.
  • Frost G; Section of Investigative Medicine, Imperial College London, London, U.K.
  • Le Roux C; Section of Investigative Medicine, Imperial College London, London, U.K.
  • Purkayastha S; Section of Investigative Medicine, Imperial College London, London, U.K.
  • Moorthy K; School of Medicine, University College Dublin, Dublin, Ireland.
  • Dhillo W; Department of Surgery and Cancer, Imperial College Healthcare National Health Service Trust, London, U.K.
  • Holst JJ; Department of Surgery and Cancer, Imperial College Healthcare National Health Service Trust, London, U.K.
  • Ahmed AR; Section of Investigative Medicine, Imperial College London, London, U.K.
  • Prevost AT; Panum Institute, Department of Biomedical Sciences and the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
  • Bloom SR; Department of Surgery and Cancer, Imperial College Healthcare National Health Service Trust, London, U.K.
  • Tan TM; Imperial Clinical Trials Unit, Imperial College London, London, U.K.
Diabetes Care ; 42(8): 1446-1453, 2019 08.
Article em En | MEDLINE | ID: mdl-31177183

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético / Peptídeo YY / Diabetes Mellitus Tipo 2 / Peptídeo 1 Semelhante ao Glucagon / Oxintomodulina / Obesidade Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Care Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético / Peptídeo YY / Diabetes Mellitus Tipo 2 / Peptídeo 1 Semelhante ao Glucagon / Oxintomodulina / Obesidade Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Care Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido